
Nick Whitehead
Investor
Get their honest, personalized take on your startup.
Sign in to pitch Nick →At a glance
- Full Name
- Nick Whitehead
- Title
- Senior Principal
- Firm
- B Capital
- Firm Type
- Venture capital firm
- Investment Stage
- Early Stage, Growth Stage
- Check Size
- Reported investment range of $25M-$60M
- Target Company Profile
- Technology-enabled healthcare companies, especially businesses using software, data, AI, payments infrastructure, or care-delivery models to change how healthcare is accessed, delivered, financed, or measured.
- Sector Focus
- Healthcare; Healthcare IT & SaaS; Digital Healthcare; healthcare insurance and payment models; AI/ML-enabled healthcare delivery and administration.
- Geographic Focus
- B Capital invests globally, with a stated presence and perspective from the U.S. to Asia; Nick is listed in the Americas.
- Location
- San Francisco, California
Background
Nick Whitehead is a Senior Principal on B Capital's investment team, based in San Francisco. His B Capital profile lists his function as Investment, his stage focus as Early Stage and Growth Stage, and his expertise as Healthcare. B Capital says he focuses on early-stage investments.
Before moving into his current investing role, Nick worked on B Capital's Platform team, supporting capital formation and follow-on fundraising for portfolio companies. Prior to B Capital, he worked in investment banking at RBS in Hong Kong and in the Financial Institutions Group at Houlihan Lokey in New York.
Nick also has operating experience: B Capital states that he founded a healthcare technology company and launched a consulting business advising early-stage startups on finance, fundraising, and operations. The Org reports that he has been with B Capital since September 2018, with roles including Investor, Principal, and Senior Principal.
Nick holds an MBA from Columbia Business School and a B.S. in Economics from the Wharton School at the University of Pennsylvania.
Investment Thesis & Focus
- Nick's stated B Capital expertise is healthcare, with stage coverage across early-stage and growth-stage companies.
- B Capital's healthcare focus includes "Healthcare IT & SaaS," "Digital Healthcare," "Biotechnology & Bio-IT," and "Healthcare Insurance and Payment Model."
- In B Capital's Cadence investment memo, Nick and co-authors emphasize continuous, AI-enabled care for chronic disease, arguing that chronic disease is not well served by episodic office visits and that reimbursement infrastructure such as RPM and APCM can support longitudinal care.
- In the Innovaccer memo authored by Nick, he frames healthcare as a market where software is central to digital transformation, especially where data can be connected across fragmented care stakeholders to improve outcomes and lower costs.
- In Sift Healthcare's Series B announcement, Nick said B Capital backed Sift because of confidence in its "AI-based platform to reshape revenue cycle processes and drive significant advancements in healthcare financial operations."
- Founder fit: strongest for companies with healthcare domain depth, evidence of measurable outcomes, a clear payer/provider or enterprise customer path, and technology that can scale care delivery, healthcare payments, data interoperability, or administrative workflows.
Notable Investments
- Cadence - AI-enabled continuous care platform for chronic disease; B Capital announced participation in Cadence's $100M Series C in June 2026, with Nick listed on the investment team.
- Sift Healthcare - AI-powered healthcare payments and revenue-cycle platform; raised a $20M Series B in May 2024 led by B Capital, with Nick quoted on the investment rationale.
- Innovaccer - Healthcare data activation and Health Cloud platform; B Capital participated in Innovaccer's $150M Series E in December 2021, with Nick authoring the investment memo.
- Capital Rx / Judi Health - Pharmacy benefit management and claims-administration infrastructure company; B Capital led Capital Rx's $106M Series C in 2022, and Nicholas Whitehead joined as a board observer.
- Positive Development - Developmental therapy provider for autistic children and families; B Capital co-led its $51.5M Series C in 2025. The Org reports Nick as a board member for Positive Development.
- PicnicHealth - Patient-centered real-world data company for life sciences research; The Org reports Nick as a board observer, and B Capital is listed as an investor in the company's Series C.
- Lively - Healthcare navigation and consumer health platform; The Org reports Nick as a board observer.
- Aetion - Real-world evidence platform for healthcare and life sciences; The Org reports Nick as an investor.
- Centivo - Healthcare plan and benefits company; The Org reports Nick as an investor.
- Evidation - Digital health measurement and real-world evidence company; Signal reports Nick as an investor.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.